Prostate-specific Antigen Nadir and Time to Nadir Predict Recurrence in Postprostatectomy Patients Treated with Salvage Radiotherapy Without Androgen Deprivation Therapy.
Mastroleo F, Villa R, Zaffaroni M, Vincini MG, Franzese C, Nicosia L, Matrone F, Donofrio A, Magli A, Triggiani L, Barra S, Timon G, Augugliaro M, Burgio V, Francolini G, Hasterok M, Miszczyk M, Simoni N, Spatola C, Alongi F, Arcangeli S, Scorsetti M, Marvaso G, Jereczek-Fossa BA.
Mastroleo F, et al. Among authors: spatola c.
Eur Urol Oncol. 2025 Dec 15:S2588-9311(25)00327-X. doi: 10.1016/j.euo.2025.12.001. Online ahead of print.
Eur Urol Oncol. 2025.
PMID: 41402161
Free article.